Peptide-based supramolecular vaccine systems()

Currently approved replication-competent and inactivated vaccines are limited by excessive reactogenicity and poor safety profiles, while subunit vaccines are often insufficiently immunogenic without co-administering exogenous adjuvants. Self-assembling peptide-, peptidomimetic-, and protein-based b...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Neill, Conor L., Shrimali, Paresh C., Clapacs, Zoe E., Files, Megan A., Rudra, Jai S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497425/
https://www.ncbi.nlm.nih.gov/pubmed/34010691
http://dx.doi.org/10.1016/j.actbio.2021.05.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497425/
https://www.ncbi.nlm.nih.gov/pubmed/34010691
http://dx.doi.org/10.1016/j.actbio.2021.05.003

Ejemplares similares